Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Verve Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +10 vs. Q1 2022
- Shares held
- 45.6M
- −1.07M (−2.3%) vs. Q1 2022
- Total value
- $695.8M
- −$368.3M (−34.6%) vs. Q1 2022
- New holders
- 27
- 32 more added
- Sold out
- 17
- 21 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $0 |
| Q1 2026 | 3 | $0 |
| Q4 2025 | 4 | $344.0K |
| Q3 2025 | 9 | $1.53M |
| Q2 2025 | 176 | $819.4M |
| Q1 2025 | 191 | $369.3M |
| Q4 2024 | 166 | $443.9M |
| Q3 2024 | 174 | $364.6M |
| Q2 2024 | 167 | $371.8M |
| Q1 2024 | 163 | $1.08B |
| Q4 2023 | 157 | $1.04B |
| Q3 2023 | 134 | $847.0M |
| Q2 2023 | 121 | $1.16B |
| Q1 2023 | 125 | $911.8M |
| Q4 2022 | 123 | $1.21B |
| Q3 2022 | 124 | $2.08B |
| Q2 2022 | 101 | $695.8M |
| Q1 2022 | 92 | $1.06B |
| Q4 2021 | 96 | $1.66B |
| Q3 2021 | 73 | $1.81B |
| Q2 2021 | 69 | $2.25B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Verve Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167.7M | 9.10% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −690,011−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −310,284−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −185,009−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −105,360−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −102,342−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −96,912−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −24,216−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −16,685−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −14,073−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −12,474−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,333−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,155−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,817−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −9,282−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −8,600−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −5,253−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |